Money in Recovery –

Jan. 13, 2018 – Neuros Medical Inc., a nerve stimulation company in Willoughby, has been able to measure the impact of its technology though studies. The most recent study showed that patients using its technology, which blocks the nerve transmission on demand with a high-frequency electrical signal, had about an 80% to 85% pain reduction rate and a 92% pill count reduction. As companies are bringing solutions to the market, it’s important that they’re not layering on cost to the health care system, said Jon Snyder, founder and chief business officer at Neuros.
Full Story @ CrainsCleveland.com